BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37578087)

  • 21. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
    Filippi M; Preziosa P; Meani A; Ciccarelli O; Mesaros S; Rovira A; Frederiksen J; Enzinger C; Barkhof F; Gasperini C; Brownlee W; Drulovic J; Montalban X; Cramer SP; Pichler A; Hagens M; Ruggieri S; Martinelli V; Miszkiel K; Tintorè M; Comi G; Dekker I; Uitdehaag B; Dujmovic-Basuroski I; Rocca MA
    Lancet Neurol; 2018 Feb; 17(2):133-142. PubMed ID: 29275979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
    Tutuncu M; Tang J; Zeid NA; Kale N; Crusan DJ; Atkinson EJ; Siva A; Pittock SJ; Pirko I; Keegan BM; Lucchinetti CF; Noseworthy JH; Rodriguez M; Weinshenker BG; Kantarci OH
    Mult Scler; 2013 Feb; 19(2):188-98. PubMed ID: 22736750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI.
    Hummel HM; Brück W; Dreha-Kulaczewski S; Gärtner J; Wuerfel J
    Mult Scler; 2013 Sep; 19(10):1330-5. PubMed ID: 23828866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple sclerosis by phenotype in Germany.
    Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
    Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".
    Polman CH; Reingold SC; Edan G; Filippi M; Hartung HP; Kappos L; Lublin FD; Metz LM; McFarland HF; O'Connor PW; Sandberg-Wollheim M; Thompson AJ; Weinshenker BG; Wolinsky JS
    Ann Neurol; 2005 Dec; 58(6):840-6. PubMed ID: 16283615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the 2010 McDonald criteria can facilitate early diagnosis of pediatric multiple sclerosis in a predominantly black cohort.
    Williams MT; Tapos DO; Juhász C
    Pediatr Neurol; 2014 Dec; 51(6):826-30. PubMed ID: 25283753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.
    Laule C; Vavasour IM; Zhao Y; Traboulsee AL; Oger J; Vavasour JD; Mackay AL; Li DK
    Mult Scler; 2010 Jun; 16(6):670-7. PubMed ID: 20558500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
    Alonso R; Quarracino C; Eizaguirre B; Cohen L; Silva B; Pita C; Rojas JI; Pappolla A; Miguez J; Patrucco L; Cristiano E; Vrech C; Volman G; Silva E; Barboza A; Deri N; Tkachuk V; Zanga G; Tavolini D; Saladino ML; Luetic G; Menichini ML; Carnero Contentti E; López P; Steinberg J; Divi P; Hryb J; Alves Pinheiro A; Carra A; Balbuena ME; Lázaro L; Fernández Liguori N; Garcea O;
    Neurol Sci; 2020 Nov; 41(11):3329-3335. PubMed ID: 32840711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
    Thompson AJ; Banwell BL; Barkhof F; Carroll WM; Coetzee T; Comi G; Correale J; Fazekas F; Filippi M; Freedman MS; Fujihara K; Galetta SL; Hartung HP; Kappos L; Lublin FD; Marrie RA; Miller AE; Miller DH; Montalban X; Mowry EM; Sorensen PS; Tintoré M; Traboulsee AL; Trojano M; Uitdehaag BMJ; Vukusic S; Waubant E; Weinshenker BG; Reingold SC; Cohen JA
    Lancet Neurol; 2018 Feb; 17(2):162-173. PubMed ID: 29275977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis.
    Thompson A
    Mult Scler; 2004 Jun; 10 Suppl 1():S2-7. PubMed ID: 15218803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis.
    Portaccio E; Fonderico M; Iaffaldano P; Pastò L; Razzolini L; Bellinvia A; De Luca G; Ragonese P; Patti F; Brescia Morra V; Cocco E; Sola P; Inglese M; Lus G; Pozzilli C; Maimone D; Lugaresi A; Gazzola P; Comi G; Pesci I; Spitaleri D; Rezzonico M; Vianello M; Avolio C; Logullo FO; Granella F; Salvetti M; Zaffaroni M; Lucisano G; Filippi M; Trojano M; Amato MP;
    JAMA Neurol; 2022 Sep; 79(9):869-878. PubMed ID: 35877104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stressful life events and the risk of primary progressive multiple sclerosis: A population-based case-control study.
    Alsharie AM; Rafiee F; Rezaeimanesh N; Moghadasi AN; Sahraian MA; Eskandarieh S
    Mult Scler Relat Disord; 2021 Jun; 51():102937. PubMed ID: 33857898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
    Antel J; Antel S; Caramanos Z; Arnold DL; Kuhlmann T
    Acta Neuropathol; 2012 May; 123(5):627-38. PubMed ID: 22327362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary progressive multiple sclerosis: clinical and paraclinical characteristics with application of the new diagnostic criteria.
    Dujmović I; Mesaros S; Pekmezović T; Lević Z; Drulović J
    Eur J Neurol; 2004 Jul; 11(7):439-44. PubMed ID: 15257680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revised diagnostic criteria of multiple sclerosis.
    Milo R; Miller A
    Autoimmun Rev; 2014; 13(4-5):518-24. PubMed ID: 24424194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
    Talbot J; Højsgaard Chow H; Mahler M; Buhelt S; Holm Hansen R; Lundell H; Vinther-Jensen T; Hellem MNN; Nielsen JE; Siebner HR; von Essen MR; Sellebjerg F
    Mult Scler Relat Disord; 2022 Dec; 68():104209. PubMed ID: 36257152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnosis of primary progressive multiple sclerosis.
    Wolinsky JS;
    J Neurol Sci; 2003 Feb; 206(2):145-52. PubMed ID: 12559502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MRI comparison between hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) and primary progressive multiple sclerosis (PPMS)].
    Saitoh BY
    Rinsho Shinkeigaku; 2014; 54(12):1162-4. PubMed ID: 25519970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.